Price movement over the last 24 hours
Acadia Healthcare Company Inc vs Toyota Motor Corp — how do they compare? Acadia Healthcare Company Inc trades at $30.84 (market cap $2.94B), while Toyota Motor Corp trades at $177.01 (market cap $215.62B). The key difference: Toyota Motor Corp is far larger — about 73.3× Acadia Healthcare Company Inc's market cap, and Toyota Motor Corp pays a 3.49% dividend while Acadia Healthcare Company Inc pays none. Which is the better fit depends on your goals.
| ACHC | TM | |
|---|---|---|
Market Cap | $2.94B | $215.62B |
Sector | Health | Consumer Cyclical |
52-Week High | $31.92 | $248.29 |
52-Week Low | $11.68 | $166.50 |
Enterprise Value | $5.45B | $379.82B |
Dividend Yield | — | 3.49% |
Signals from Pluang's Aura AI — not financial advice
ACHC trades at $31.09, down 2.57% today but maintains a bullish technical outlook with strong moving average support. The company shows operational strength with three consecutive earnings beats, though profitability remains challenged with a -32.84% net margin. Analyst consensus is strongly bullish with 68% buy ratings, while recent news highlights the company's strategic shift toward profitability and rising behavioral health demand.
The stock presents a mixed opportunity with strong technical momentum and analyst support offset by persistent profitability challenges. Key catalysts include continued earnings outperformance and successful execution of the turnaround strategy, while risks center on margin pressures and high short interest that could limit upside potential.
Toyota Motor (TM) trades at $179.43, up 2.77% today, with strong technical momentum and bullish moving average signals. The company demonstrates solid fundamentals with a P/E of 9.85 and consistent earnings beats, including Q1 2026 EPS of $4.00 versus $3.11 expected. Recent news highlights a $3.6 billion Texas plant expansion to shift Tacoma production from Mexico, signaling strategic US investment. Operating cash flow remains robust at $3.70 trillion for 2025, though net cash flow turned negative due to significant capital expenditures.
Toyota presents a compelling value opportunity with attractive valuation multiples and hybrid vehicle leadership, but faces risks from declining global sales and rising debt levels. Analyst sentiment is mixed with 37.5% buy ratings versus 62.5% hold, reflecting cautious optimism amid competitive pressures. The stock's current technical strength near resistance at $180-183 suggests potential for near-term consolidation before further upside.
Trailing returns across standard periods
Latest headlines on both assets
Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.
Read more on ACHC →Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →